Short-course treatment for recent hepatitis C: some courses may be too short
US emergency department testing finds a lot of people with new – and returning – HIV infections
Top 5 HIV cure and vaccine stories from CROI 2020
What did you miss on ageing and co-morbidities from CROI 2020?
Top 10 HIV prevention stories from CROI 2020
Maternal and child health highlights from CROI 2020
Hepatitis C spreading rapidly among HIV-positive MSM in Thailand and chemsex is a key risk factor
An HIV cure may work differently for women and men
HIV PrEP also prevents hepatitis B – and works better than the hepatitis B vaccine
Evaluating point-of-care early infant diagnosis in Zambia and Zimbabwe
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells
Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP
Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV
HIV-positive people with fatty liver disease are at high risk for fibrosis
Weight gain after starting HIV treatment may have genetic influences
Child with HIV maintains viral suppression for three years off treatment
Diagnostic challenges with PrEP use during early HIV infection
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin
